METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE FAMILY ENTEROBACTERIACEAE HAVING AN ATTENUATED EXPRESSION OF A gshA GENE

US2016348089A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016348089-A1
Application numberUS-201615165606-A
CountryUS
Kind codeA1
Filing dateMay 26, 2016
Priority dateMay 28, 2015
Publication dateDec 1, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides a method for producing an L-amino acid such as a branched-chain L-amino acid by fermentation using a bacterium of the family Enterobacteriaceae, particularly a bacterium belonging to the genus Escherichia , which has been modified to attenuate expression of the gshA gene.

First claim

Opening claim text (preview).

1 . A method for producing an L-amino acid comprising: (i) cultivating an L-amino acid-producing bacterium of the family Enterobacteriaceae in a culture medium to produce the L-amino acid in the culture medium, the bacterium, or both; and (ii) collecting said L-amino acid from the culture medium, the bacterium, or both, wherein said bacterium has been modified to attenuate expression of a gshA gene. 2 . The method according to claim 1 , wherein said bacterium belongs to the genus Escherichia. 3 . The method according to claim 2 , wherein said bacterium is Escherichia coli. 4 . The method according to claim 1 , wherein said bacterium belongs to the genus Pantoea. 5 . The method according to claim 4 , wherein said bacterium is Pantoea ananatis. 6 . The method according to claim 1 , wherein said expression of the gshA gene is attenuated by inactivation of the gshA gene. 7 . The method according to claim 6 , wherein said gshA gene is deleted. 8 . The method according to claim 1 , wherein said gshA gene is selected from the group consisting of: (A) a DNA comprising the nucleotide sequence of SEQ ID NO: 1; (B) a DNA comprising a variant nucleotide sequence of SEQ ID NO: 1 due to the degeneracy of the genetic code; (C) a DNA having an identity of not less than 60% with respect to the entire nucleotide sequence of SEQ ID NO: 1, and wherein said DNA encodes a protein having an activity of γ-glutamate-cysteine ligase; (D) a DNA encoding a protein comprising the amino acid sequence of SEQ ID NO: 2; and (E) a DNA encoding a protein comprising the amino acid sequence of SEQ ID NO: 2, but which includes one or more mutations comprising substitution, deletion, insertion, or addition of one or several amino acid residues, and wherein said protein has the activity of γ-glutamate-cysteine ligase. (F) a DNA encoding a protein having an identity of not less than 65% with respect to the entire amino acid sequence of SEQ ID NO: 2, wherein said protein has the activity of γ-glutamate-cysteine ligase. 9 . The method according to claim 1 , wherein said L-amino acid is selected from the group consisting of an aromatic L-amino acid and a non-aromatic L-amino acid. 10 . The method according to claim 9 , wherein said aromatic L-amino acid is selected from the group consisting of L-phenylalanine, L-tryptophan, and L-tyrosine. 11 . The method according to claim 9 , wherein said non-aromatic L-amino acid is selected from the group consisting of L-alanine, L-arginine, L-asparagine, L-aspartic acid, L-citrulline, L-cysteine, L-glutamic acid, L-glutamine, glycine, L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, L-ornithine, L-proline, L-serine, L-threonine, and L-valine. 12 . The method according to claim 1 , wherein said L-amino acid is a branched-chain L-amino acid. 13 . The method according to claim 12 , wherein said branched-chain L-amino acid is selected from the group consisting of L-isoleucine, L-leucine, and L-valine. 14 . The method according to claim 13 , wherein said L-amino acid is L-valine.

Assignees

Inventors

Classifications

  • Alanine; Leucine; Isoleucine; Serine; Homoserine · CPC title

  • Genes encoding for enzymes or proenzymes · CPC title

  • Glutamate-cysteine ligase (6.3.2.2) · CPC title

  • Methionine; Cysteine; Cystine · CPC title

  • Lysine; Diaminopimelic acid; Threonine; Valine · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016348089A1 cover?
The present invention provides a method for producing an L-amino acid such as a branched-chain L-amino acid by fermentation using a bacterium of the family Enterobacteriaceae, particularly a bacterium belonging to the genus Escherichia , which has been modified to attenuate expression of the gshA gene.
Who is the assignee on this patent?
Ajinomoto Kk
What technology area does this patent fall under?
Primary CPC classification C12N9/93. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Dec 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).